Dr. Srinivasa B

Medical Oncology, Immunotherapy, Breast cancer, GI cancer, Lung cancer, Multiple Myeloma,Lymphoma, Clinical research and tumor genetics.

Was a Gold Medalist in 2014 ,He was part of clinical trial experience as Co-Investigator and Principle Investigator and Has various National and International publications to his credit.

• ASCO – American society of clinical Oncology
• ESMO- European society of Medical Oncology

• He Has 15+ Publications to his credit few among them are
• Prospective Analysis of Patients with Metastatic Breast Cancer receiving Eribulin Mesylate as Second or More Lines of Chemotherapy: An Indian Experience- clinical medicine insights.Oncology 12(2018)
• Efficacy study of metronomic chemotherapy in metastatic triple negative Breast cancer and Correlation with VEGF , TSP Levels.
• Prospective analysis of patients treated with chemoterapy in Metastatic Adenocarcinoma of lung-single centre experience. Journal of cancer therapy,8,838-844